Yiannis Monovoukas, PhD, MBA, is the former Chairman, President, and CEO of TEI Biosciences Inc. and TEI Medical Inc., two regenerative medicine companies founded on technology generated at MIT. Both companies were sold to Integra LifeSciences in 2015. Prior to joining TEI, Dr. Monovoukas was President and CEO of Thermo Fibergen, a Thermo Electron (now Thermo Fisher Scientific) spin-off. Dr. Monovoukas founded and is currently the President and CEO of Helios Global Investments and Helios Cardiovascular, as well as the Co-Founder, President, and CEO of AuraGen Aesthetics.
Dr. Monovoukas holds a BS degree from Columbia University and MS and PhD degrees from Stanford University, all in chemical engineering, as well as an MBA from the Harvard Business School.